Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06661850 · ClinicalTrials.gov registry record
Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes
A clinical trial of Discogenic Low Back Pain, sponsored by Aclarion.
- Recruiting
- Registry status
- 300
- Enrollment target
- 7
- Study locations
NCT06661850: Recruiting study of Discogenic Low Back Pain, sponsored by Aclarion.
NCT06661850 is a study of Discogenic Low Back Pain that is actively recruiting participants, run by Aclarion. The registered enrollment target is 300 participants. The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06661850, a study of Discogenic Low Back Pain, is actively recruiting participants, sponsored by Aclarion.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient."
Primary Outcome
The primary endpoint is change in back pain as measured on a 100mm VAS Back at 12 months compared to baseline. VAS is a measurement instrument that measures the amount of pain that a subject feels ranges across a continuum from none to an extreme amount of pain. Higher scores closer to the extreme pain range indicate worse outcome.
Conditions Studied
Interventions
- PROCEDURE Fusion or TDR determined by investigator.
Study Locations (7)
California
- Scripps Health - La Jolla
- USC Keck Medical Center - Los Angeles
Illinois
- Northwestern University - Chicago
- Advocate Aurora Research Institute - Park Ridge
Florida
- University of Miami - Miami
Maryland
- Johns Hopkins Medicine - Baltimore
Texas
- Texas Back Institute - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-12-31 |
What NCT06661850 shows while recruiting
NCT06661850 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Discogenic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Fusion or TDR determined by investigator. is the first listed.
NCT06661850 lists 7 locations in 5 states (California, Illinois, Florida).
Frequently Asked Questions
What is clinical trial NCT06661850 about?
NCT06661850 is a clinical study titled "Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes". This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. ...
What is the current status of trial NCT06661850?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-06-11. Estimated completion is 2027-12-31.
What conditions does trial NCT06661850 study?
This clinical trial studies the following conditions: Discogenic Low Back Pain.
What interventions are being tested in trial NCT06661850?
The interventions under investigation include: Fusion or TDR determined by investigator. (PROCEDURE).
Who is sponsoring clinical trial NCT06661850?
This trial is sponsored by Aclarion, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06661850 being conducted?
This trial has 7 study locations across California, Florida, Illinois, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Discogenic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI